- Filed
- May 12, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 5, 2026 | 725.17M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 744.4M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 451.4M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $70.6M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $36.5M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $3.06B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $3.06B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $3.05B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $2.36B |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $10.16B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $9.71B |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $5.06B |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $5.05B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.94B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.55B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $6.5B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $6.18B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $6.46B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $5.55B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $16.66B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $15.89B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.35 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.03 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.35 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.03 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $497M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $44.4M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$227.1M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | $8.8M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$251.9M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$39.3M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $409.3M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $5.4M |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.73B |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $13.5M |